Tesla (TSLA) hit fresh 2025 lows on Wednesday, extending a big February sell-off and failing to bounce with the broader ...

When it comes to up-and-coming stocks, it's easy to get wide-eyed over impressive short-term performances. After all, everyone dreams of getting a piece of the next disruptor like Apple Inc. (ticker: ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Ryan said he's received complaints about scheduling, wait times, billing, and care at CareMount and Crystal Run.

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...

Eli Lilly & Co. said Tuesday it's cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will also ...

This writer noticed that UK stock investors have been buying an obscure share that fell 26% yesterday but is still up nearly ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...